The burden of HIV and opportunistic infections (Ol), particularly Mycobacterium tuberculosis (TB) are profoundly eroding infant survival, life expectancy, the economy and health care in Sub-Saharan Africa. Clinical, operational and translational research are recognized as essential responses to the epidemic. However, resource constraints, economic and health priorities limit capacity to train effective investigators and scientists. Research training and increased opportunities for researchers to develop internationally competitive skills are essential for effective responses to the HIV and TB epidemics. The proposed ICOHRTA collaboration between the Biomedical and Research Training Institute (BRTI), University of Zimbabwe (UZ) and Stanford University will provide clinical, laboratory, epidemiological, statistical and operational research training in an academic framework. The primary aim is to enable young African scientists to improve their research capacity: to design, implement and report on meaningful and relevant research. In collaboration with current clinical trials in HIV and TB prevention and treatment, the program will provide three critical areas of training: 1) Support and attachment of students to active clinical and laboratory research projects in Zimbabwe including field, laboratory, clinical, operational and health systems'delivery studies focused on prevention and treatment of HIV, TB, and Ol. 2) For post-graduate clinicians, a 2-year mentored clinical experience in HIV, TB and opportunistic infections and the opportunity for practical clinical experience in HIV clinical trials, prevention and care at Stanford University, the University of Colorado, the Children's Hospital of Oakland, and other US-medical schools and hospitals. 3) Training and experience in research for post-doctoral fellows from the US who will participate in the BRTI short-training courses as part of ongoing, substantial mentored clinical research with US and UZ faculty-investigators. To increase access to literature and developments in treatment and prevention, the program will develop, test and evaluate internet-based training and teaching tools to access interactive courses and training in good clinical practice, epidemiology, basic science, ethics, and translational research on the web.
The aim i s to equip students in the health sciences and young clinicians from Zimbabwe and the US to meet the challenges of these devastating epidemics through robust training in research methods and participation in clinical trials, operational and laboratory studies in Zimbabwe.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Training Cooperative Agreements (U2R)
Project #
5U2RTW006878-05
Application #
7648184
Study Section
Special Emphasis Panel (ZRG1-ICP-2 (52))
Program Officer
Mcdermott, Jeanne
Project Start
2005-09-26
Project End
2011-06-30
Budget Start
2009-07-01
Budget End
2011-06-30
Support Year
5
Fiscal Year
2009
Total Cost
$117,314
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Chimukangara, Benjamin; Varyani, Bhavini; Shamu, Tinei et al. (2017) HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing. J Virol Methods 243:151-157
Chimukangara, Benjamin; Gwanzura, Lovemore; Mitchell, Rebecca et al. (2014) Drug resistance mutations from whole blood proviral DNA among patients on antiretroviral drugs in Zimbabwe. Curr HIV Res 12:309-16
Patel, Rena; Ratner, Jamie; Gore-Felton, Cheryl et al. (2012) HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care 24:358-68
Banks, Lauren; Gholamin, Sharareh; White, Elizabeth et al. (2012) Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1. J AIDS Clin Res 3:141-147
El-Khatib, Ziad; Delong, Allison K; Katzenstein, David et al. (2011) Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa. J AIDS Clin Res 2:
Tshabalala, Mqondisi; Manasa, Justen; Zijenah, Lynn S et al. (2011) Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe. PLoS One 6:e21241
El-Khatib, Ziad; Katzenstein, David; Marrone, Gaetano et al. (2011) Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa. PLoS One 6:e17518
White, Elizabeth Johnston; McColgan, Bryan; Kassaye, Seble et al. (2010) Unusual five amino acid insert within subtype C HIV-1 envelope contributes to dual-tropism (X4R5). AIDS 24:1063-4
El-Khatib, Ziad; Ekstrom, Anna Mia; Ledwaba, Johanna et al. (2010) Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa. AIDS 24:1679-87
Bulterys, Philip L; Dalai, Sudeb C; Katzenstein, David A (2010) Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission. Clin Perinatol 37:739-50, viii

Showing the most recent 10 out of 15 publications